CIK 0001937993 · <br>Emerging growth company
Cadrenal Therapeutics, Inc.
Sign in to watch- Ticker
- CVKD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880860746
- Phone
- 904-300-0701
- Business address
- 822 A1A NORTH, SUITE 306, PONTE VEDRA, FL, 32082
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-10 | Pham Quang X CEO and Chairman | Gift | −50,000 | 3,275,000 | ||
| 2024-04-02 | Cole Jeffrey Scott Chief Operating Officer | Grant or award · Stock Options | +150,000 | 150,000 | ||
| 2024-01-18 | Zelenkofske Steven Director | Grant or award · Stock Options | +100,000 | 100,000 | ||
| 2024-01-18 | MURPHY JOHN RAYMOND Director | Grant or award · Stock Options | +100,000 | 100,000 | ||
| 2024-01-18 | Lisicki Robert Director | Grant or award · Stock Options | +50,000 | 50,000 | ||
| 2024-01-18 | Pham Quang X Chief Executive Officer | Grant or award · Stock Options | +150,000 | 150,000 | ||
| 2024-01-18 | Szot Matthew K Chief Financial Officer | Grant or award · Stock Options | +250,000 | 250,000 | ||
| 2024-01-18 | WILSON GLYNN Director | Grant or award · Stock Options | +70,000 | 70,000 | ||
| 2024-01-18 | LOSORDO DOUGLAS W Chief Medical Officer | Grant or award · Stock Options | +150,000 | 150,000 | ||
| 2023-10-23 | Pham Quang X CEO and Chairman | Gift | −85,000 | 3,325,000 | ||
| 2023-10-05 | MURPHY JOHN RAYMOND Director | Purchase | +2,669 | $0.69 | $2K | 614,792 |
| 2023-10-04 | MURPHY JOHN RAYMOND Director | Purchase | +17,331 | $0.70 | $12K | 612,123 |
| 2023-09-05 | Pham Quang X CEO and Chairman | Purchase | +20,000 | $0.91 | $18K | 3,390,000 |
| 2023-09-05 | Pham Quang X CEO and Chairman | Purchase | +20,000 | $0.90 | $18K | 3,410,000 |
| 2023-09-01 | Pham Quang X CEO and Chairman | Purchase | +10,000 | $0.93 | $9K | 3,310,000 |
| 2023-09-01 | Pham Quang X CEO and Chairman | Purchase | +20,000 | $0.93 | $19K | 3,330,000 |
| 2023-09-01 | Pham Quang X CEO and Chairman | Purchase | +20,000 | $0.92 | $18K | 3,350,000 |
| 2023-09-01 | Pham Quang X CEO and Chairman | Purchase | +10,000 | $0.92 | $9K | 3,360,000 |
| 2023-09-01 | Pham Quang X CEO and Chairman | Purchase | +10,000 | $0.84 | $8K | 3,370,000 |
| 2023-07-23 | Lisicki Robert Director | Grant or award · Stock options | +75,000 | 75,000 |
Page 4 of 5 · 88 trades